Get all your news in one place.
100's of premium titles.
One app.
Start reading
Daily Mirror
Daily Mirror
National
Chris Kitching

Coronavirus vaccine guidance for children and parents as UK approves Pfizer jab

Britain will begin vaccinating people against coronavirus next week and advisers have set out a list of priority groups - including guidance for parents.

The elderly, vulnerable and health and social care workers on the frontline will be among the first to receive a jab.

After the UK became the first nation to authorise a vaccine for emergency use, parents might be wondering whether they should get their children vaccinated or whether the jab will be compulsory for children.

The priority list does not include children under 16, and the vaccine should only be offered to kids "at very high risk of exposure and serious outcomes", according to official guidance.

Health Secretary Matt Hancock has said the vaccine would not be compulsory for children and that uptake would be voluntary.

Click here for our live blog with the latest updates on the Pfizer vaccine and Covid-19 pandemic.

The vaccine should only be offered to children at "very high risk" (stock photo) (Getty Images/iStockphoto)

The Joint Committee on Vaccination and Immunisation (JCVI) updated its advice on priority groups for vaccination after the UK approved Pfizer's jab for emergency use on Wednesday.

Studies found that the Pfizer jab was 95% effective and worked across all age groups.

What is the advice for children?

The JCVI said most children should not be offered the jab at this time.

It said: "Following infection, almost all children will have asymptomatic infection or mild disease.

"There are very limited data on vaccination in adolescents, with no data on vaccination in younger children, at this time.

This graphic explains how Pfizer's coronavirus vaccine works (Press Association Images)

"The Committee advises that only those children at very high risk of exposure and serious outcomes, such as older children with severe neuro-disabilities that require residential care, should be offered vaccination.

"Clinicians should discuss the risks and benefits of vaccination with a person with parental responsibility, who should be told about the paucity of safety data for the vaccine in children aged over 16 years.

"More detail on vaccination in children is set out in the Green Book – Immunisation Against Infectious Disease."

The JCVI said further research is being carried out to understand the safety of Covid-19 vaccines in pregnancy and children.

It said: "As trials in children and pregnant women are completed, we will also gain a better understanding of the safety and effectiveness of the vaccines in these persons."

Should pregnant women get the jab?

Pregnant women or women planning a pregnancy should not receive a coronavirus vaccine because any potential risks are still unknown, the new guidance says.

The JCVI recommended pregnant women not come forward to receive the jab, writing: "There are no data as yet on the safety of Covid-19 vaccines in pregnancy, either from human or animal studies.

"Given the lack of evidence, JCVI favours a precautionary approach, and does not currently advise Covid-19 vaccination in pregnancy.

"Women should be advised not to come forward for vaccination if they may be pregnant or are planning a pregnancy within three months of the first dose."

It added: "Data are anticipated which will inform discussions on vaccination in pregnancy.

"JCVI will review these as soon as they become available."

Who is on the priority list?

The JCVI said care home residents were among those who should be given the jab first.

The committee examined data on who suffers the worst outcomes from coronavirus and who is at highest risk of death.

It published interim guidance earlier in the year, but this has now been amended slightly.

In the new guidance, those who are deemed to be "clinically extremely vulnerable" have moved higher up the priority list.

Studies found that the Pfizer jab was 95% effective (REUTERS)

The priority list for "phase one" of the Covid-19 vaccination programme is:

1. Residents in a care home for older adults and their carers

2. All those 80 years of age and over and frontline health and social care workers

3. All those 75 years of age and over

4. All those 70 years of age and over and people deemed to be clinically extremely vulnerable.

5. All those 65 years of age and over

6. All individuals aged 16 years to 64 years with underlying health conditions which put them at higher risk of serious disease and mortality

7. All those 60 years of age and over

8. All those 55 years of age and over

9. All those 50 years of age and over

The UK has ordered 40million doses of the Pfizer vaccine, enough to vaccinate 20million people - or about a third of the population - with two doses, given 21 days apart.

Around 10million doses are expected to be available for use in the UK in the coming weeks for priority groups, including healthcare workers, with 800,000 doses arriving next week.

Vaccines developed by Moderna and AstraZeneca/Oxford University could be given emergency use approval soon.

The UK has secured access to 100million doses of the AstraZeneca/Oxford University vaccine, which is almost enough for most of the population.

It also belatedly struck a deals for seven million doses of the jab on offer from Moderna in the US.

The deals cover four different classes: adenoviral vaccines, mRNA vaccines, inactivated whole virus vaccines and protein adjuvant vaccines.

The UK has secured access to:

- 100million doses of the Oxford vaccine

- 60million doses of the Novavax vaccine

- Some 30million doses from Janssen

- 40million doses of the Pfizer/BioNTech vaccine - the first agreement the firms signed with any government

- 60million doses of a vaccine being developed by Valneva

- 60million doses of protein adjuvant vaccine from GlaxoSmithKline (GSK) and Sanofi Pasteur

- Seven million doses of the jab on offer from Moderna in the US.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.